Is there a heart rate paradox - Demystification of the myths?

Journal of Internal Medicine

Volumn 266, Issue 3, 2009, Pages 242-247

  Kjekshus, J ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; NOTE; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; HEART RATE; HUMANS; HYPERTENSION; MIDDLE AGED; PATIENT SELECTION;

EID: 68949110315     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02143.x     Document Type: Note

References (39)

1. Kannel WB, Kannel C, Paffenberger RS Jr., Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987 113 : 1489 94.
2. Palatini P, Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens 2004 26 : 637 44.
3. Sajadieh A, Wendelboe Nielsen O, Rasmussen V, Hein HO, Abedini S, Fischer Hansen J. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004 25 : 363 70.
4. Kaye D, Smirk B, Finch S, Williams C, Esler MD. Interaction between cardiac sympathetic drive and heart rate in heart failure. J Am Coll Cardiol 2004 44 : 2008 15.
5. Pepper GS, Lee RW. Sympathetic activation in heart failure and its treatment with β-blockade. Arch Intern Med 1999 159 : 225 34.
6. Shigetoh Y, Adachi H, Yamagishi S, Fukami A. Higher heart rate may predispose to obesity and diabetes mellitus: 20 year prospective study in a general population. Am J Hypertens 2009 22 : 151 5.
7. Williams PT, Haskell WL, Vranizan KM et al. Associations of resting heart rate with concentrations of lipoprotein subfractions in sedentary men. Circulation 1985 71 : 441 9.
8. Kolloch R, Legler UF, Champion A et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the international verapamil-SR/trandolapril study (INVEST). Eur Heart J 2008 29 : 1327 34.
9. Okin PM, Wachtell K, Kjeldsen SE et al. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients. The Life study. Circ Arrhythmia Electrophysiol 2008 1 : 337 43.
10. Yusuf S, Peto R, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovasc Dis 1985 14 : 335 71.
11. Shibita MC, Flather MD, Wang D. Systematic review of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail 2001 3 : 351 7.
12. Gundersen T, Grøttum P, Pedersen T, Kjekshus JK. Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest. Am J Cardiol 1986 58 : 20 4.
13. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986 57 : 43F 9F.
14. Lechat P, Hulot J-S, Escolano S et al. Heart rate and cardiac rhythm relationship with bisoprolol benefit in chronic heart failure in CIBISII trial. Circulation 2001 103 : 1428 33.
15. Kjekshus J. The effect of heart rate reduction on survival in heart failure. Medicographia 2006 28 : 238 44.
16. Colucci WS, Kolias TJ, Kirkwood FA et al. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction. The reversal of ventricular remodeling with toprol-xl (REVERT) trial. Circulation 2007 116 : 49 56.
17. Logeart D, Gueffet J-P, Rouzet F et al. Heart rate per se impacts cardiac function in patients with systolic heart failure and pacing: a pilot study. Eur J Heart Fail 2009 11 : 53 7.
18. Thackrey SDR, Gosh JM, Wright GA et al. The effect of altering heart rate on ventricular function in patients with heart failure treated with β-blockers. Am Heart J 2006 152 : 713 : 9 13.
19. Orso F, Baldasseroni S, Fabbri G et al. Role of beta-blockers in patients admitted for worsening heart failure in a real world setting: data from the Italian Survey on Acute Heart Failure. Eur J Heart Fail 2009 11 : 77 84.
20. Messerli FH, Bangalore S, Yao SS, Steinberg JS. Cardioprotection with beta-blockers: myths, facts and Pascal's wager. J Int Med 2009 266 : 232 241.
21. Bangalore S, Wild D, Parkar S, Kukin M, Messerli F. Beta-blockers for primary prevention of heart failure in patients with hypertension. J Am Coll Cardiol 2008 52 : 1052 72.
22. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003 362 : 1527 35.
23. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressure averaging 90through 114 mmHg. JAMA 1970 213 : 1143 52.
24. Lund-Johansen P. Anti-hypertensive drugs: haemodynamic effects. In : McInnes GT, ed. Clinical Pharmacology and Therapeutics of Hypertension. Oxford : Elsevier, 2008 57 83.
25. Bangalore S, Sawhney S, Messerli F. Relation of beta-blocker- induced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol 2008 52 : 1482 9.
26. Wiklund O, Hulthe J, Wikstrand J, Schmidt C, Olofsson S-O, Bondjers G. Effect of controlled release/extended release metoprolol on carotid intimamedia thickness in patients with hypercholesterolemia: a 3-year randomized study. Stroke 2002 33 : 572 7.
27. Cruickshank JM. Are we misunderstanding beta-blockers. Int J Cardiol 2007 120 : 10 27.
28. Williams B, Lacy PS, Thom SM et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the conduit artery function evaluation (CAFÉ) study. Circulation 2006 113 : 1213 25.
29. Blix AB, Kjekshus J, Enge I, Bergan A. Myocardial blood flow in the diving seal. Acta Physiol Scand 1976 96 : 277 80.
30. Poise Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008 371 : 1839 47.
31. COMMIT Collaborative group. Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo controlled trial. Lancet 2005 366 : 1622 32.
32. Poldermans D, Boersma E, Bax JJ et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Eng J Med 1999 341 : 1789 94.
33. Schnabel RB, Sullivan LM, Levy D et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a communitybased cohort study. Lancet 2009 373 : 739 45.
34. Külkamp V, Schirdewan A, Stanl K, Homberg M, Ploch M, Beck OA. Use of metoprolol CR/XL to maintain sinusrythm after conversion from persistent atrial fibrillation. J Am Coll Cardiol 2000 36 : 139 46.
35. Roy D, Talajic M, Nattel S et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Eng J Med 2008 358 : 2667 77.
36. Bangalore S, Parkar S, Grossman E, Messerli FH. A meta-analysis of 94 492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Am J Cardiol 2007 100 : 1254 62.
37. Bell DSH. Optimizing treatment of diabetes and cardiovascular disease with combined α,β-blockade. Curr Med Res Opin 2005 21 : 1191 200.
38. Landray MJ, Toescu V, Kendall MJ. The cardioprotective role of β-blockers in patients with diabetes mellitus. J Clin Pharm Ther 2002 27 : 233 42.
39. Sawicki PT, Siebenhofer A. Beta-blockers and diabetes mellitus. J Clin Basic Cardiol 2001 4 : 17.